Replication_NN
of_IN
human_JJ
immunodeficiency_NN
virus-1_NN
in_IN
primary_JJ
human_JJ
T_NN
cells_NNS
is_VBZ
dependent_JJ
on_IN
the_DT
autocrine_JJ
secretion_NN
of_IN
tumor_NN
necrosis_NN
factor_NN
through_IN
the_DT
control_NN
of_IN
nuclear_JJ
factor-kappa_NN
B_NN
activation_NN
._.

Tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
-_:
alpha_NN
controls_VBZ
T-cell_NN
activation_NN
and_CC
is_VBZ
a_DT
major_JJ
inducer_NN
of_IN
human_JJ
immunodeficiency_NN
virus_NN
-LRB-_-LRB-
HIV_NN
-RRB-_-RRB-
-1_CD
replication_NN
in_IN
chronically_RB
infected_VBN
cells_NNS
._.

Therefore_RB
,_,
we_PRP
have_VBP
investigated_VBN
its_PRP$
role_NN
in_IN
primary_JJ
cultures_NNS
of_IN
HIV-infected_JJ
human_JJ
T_NN
lymphocytes_NNS
by_IN
using_VBG
neutralizing_VBG
anti-TNF-alpha_JJ
antibodies_NNS
or_CC
TNF-alpha_NN
._.

Primary_JJ
resting_VBG
T_NN
lymphocytes_NNS
produced_VBD
TNF-alpha_NN
and_CC
supported_VBD
HIV_NN
replication_NN
after_IN
T-cell_NN
receptor_NN
activation_NN
._.

Addition_NN
of_IN
neutralizing_VBG
anti-TNF-alpha_JJ
antibodies_NNS
drastically_RB
reduced_VBD
p24_NN
antigen_NN
release_NN
and_CC
prevented_VBD
CD4_NN
+_CC
cell_NN
depletion_NN
associated_VBN
with_IN
infection_NN
._.

Anti-TNF-alpha_NN
also_RB
prevented_VBD
nuclear_JJ
factor-kappa_NN
B_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
-RRB-_-RRB-
activation_NN
,_,
and_CC
a_DT
good_JJ
correlation_NN
between_IN
this_DT
inhibition_NN
and_CC
inhibition_NN
of_IN
HIV_NN
replication_NN
was_VBD
observed_VBN
._.

Moreover_RB
,_,
supplementing_VBG
the_DT
cultures_NNS
with_IN
high_JJ
doses_NNS
of_IN
IL-2_NN
reverted_VBD
anti-TNF-alpha_JJ
inhibition_NN
of_IN
cell_NN
proliferation_NN
but_CC
did_VBD
not_RB
affect_VB
the_DT
inhibition_NN
of_IN
HIV_NN
p24_NN
antigen_NN
release_NN
or_CC
NF-kappa_NN
B_NN
activation_NN
in_IN
the_DT
same_JJ
cultures_NNS
._.

Moreover_RB
,_,
anti-TNF-alpha_NN
inhibited_VBD
HIV-1_NN
long_JJ
terminal_JJ
repeat_NN
-LRB-_-LRB-
LTR_NN
-RRB-_-RRB-
-_:
driven_JJ
transcription_NN
of_IN
a_DT
reporter_NN
gene_NN
in_IN
primary_JJ
T_NN
cells_NNS
in_IN
response_NN
to_TO
activation_NN
,_,
either_CC
in_IN
the_DT
presence_NN
or_CC
the_DT
absence_NN
of_IN
HIV-1_NN
Tat_NN
._.

Our_PRP$
results_NNS
support_VBP
an_DT
important_JJ
role_NN
for_IN
autocrine_JJ
TNF-alpha_NN
secretion_NN
in_IN
controlling_VBG
HIV_NN
replication_NN
in_IN
primary_JJ
T_NN
cells_NNS
because_IN
of_IN
its_PRP$
ability_NN
to_TO
maintain_VB
NF-kappa_NN
B_NN
elevated_JJ
in_IN
the_DT
nucleus_NN
of_IN
T_NN
cells_NNS
._.

